CBAY - CymaBay Therapeutics Inc. (CBAY) CEO Sujal Shah on Q2 2021 Results - Earnings Call Transcript
CymaBay Therapeutics, Inc. (CBAY) Q2 2021 Earnings Conference Call August 12, 2021 04:30 PM ET Company Participants Dan Menold - Vice President, Finance Sujal Shah - Chief Executive Officer Dennis Kim - Chief Medical Officer Chuck McWherter - Chief Scientific Officer Conference Call Participants Yasmeen Rahimi - Piper Sandler Steven Seedhouse - Raymond James Patrick Dolezal - LifeSci Capital Matt Hershenhorn - Oppenheimer & Company Emily Bodnar - Cantor Fitzgerald Mike Kratky - SVB Leerink William Wood - B. Riley Thomas Yip - H.C. Wainwright Presentation Operator Good day ladies and gentlemen and welcome to CymaBay's Second Quarter 2021 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode. Following the formal remarks, we will open the call for your questions. Please be advised that the call will be recorded at the company's request. It is also being webcast live on the Investors
For further details see:
CymaBay Therapeutics, Inc. (CBAY) CEO Sujal Shah on Q2 2021 Results - Earnings Call Transcript